Sort
85,873 grants matching “alzheimers”
mGluR5 and Phase State Dependent Synaptic Loss in Alzheimer's Disease
$835,423Stephen M Strittmatter · Yale University · R01 · FY2021 · AG
Therapeutic effects of APOE regulation via LNP-RNA formulations in Alzheimer's disease
$835,417Yizhou Dong · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG
Quantitative MRI-based cerebral oxygen metabolism in Alzheimer's disease
$835,389Yi Wang · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AG
Center to Accelerate Population Research in Alzheimer's (CAPRA)
$835,339Julie Pw Bynum · University Of Michigan At Ann Arbor · P30 · FY2023 · AG
Mechanisms of cognitive impairment caused by atherosclerosis and red blood cell released ATP
$835,288Pingnian He · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2024 · NS
Innate Immunity Stimulation Effects on Biomarkers, Cognition, and the Vascular Amyloid Proteome in a Squirrel Monkey Model of Sporadic CAA
$835,220Henrieta Scholtzova · New York University School Of Medicine · R01 · FY2025 · NS
Novel automated performance-based ADL outcomes for early AD clinical trials
$835,178Gad Asher Marshall · Brigham And Women'S Hospital · R01 · FY2020 · AG
Characterizing the evolution of Subjective Cognitive Decline in preclinical Alzheimer's disease
$835,070Rebecca E Amariglio · Brigham And Women'S Hospital · R01 · FY2019 · AG
Presenilin1/gamma-secretase regulate the VEGFA/VEGFR2 brain angiogenesis inhibited by FAD mutants.
$834,945Nikolaos Robakis · Icahn School Of Medicine At Mount Sinai · R56 · FY2023 · AG
Enhanced Quality in Primary Care for Elders with Diabetes and Dementia (EQUIPED-ADRD)
$834,894Caroline S Blaum · New York University School Of Medicine · R33 · FY2018 · AG
Trial to Reduce Antimicrobial Use in Nursing home residents with Alzheimer's disease and other Dementias (TRAIN-AD)
$834,838Susan L Mitchell · Hebrew Rehabilitation Center For Aged · R37 · FY2018 · AG
Robust detection of atrophy over short intervals in AD and FTLD
$834,693Bradford C Dickerson · Massachusetts General Hospital · R01 · FY2024 · AG
Robust detection of atrophy over short intervals in AD and FTLD
$834,693Bradford C Dickerson · Massachusetts General Hospital · R01 · FY2023 · AG
Role of N-terminal acetylation in alpha synuclein stability, function, and therapeutic targeting in synucleinopathies
$834,688Elizabeth Rhoades · University Of Pennsylvania · R01 · FY2025 · NS
The cross-talk between a-Synucleinopathies and T cell immunity in ADRD
$834,685Xiaobo Mao · Johns Hopkins University · R01 · FY2024 · AG
Theranostic CAR-T Targeting Senescence in Alzheimer's
$834,627Lina Cui · University Of Florida · R61 · FY2025 · AG
Visual-somatosensory integration as a novel marker of Alzheimer's disease
$834,557Jeannette R. Mahoney · Albert Einstein College Of Medicine · R01 · FY2022 · AG
ADNI Psychometrics
$834,522Paul K Crane · University Of Washington · R01 · FY2020 · AG
Sex-specific trajectories in epigenomic regulation of brain patterning
$834,436Flora M Vaccarino · Yale University · R01 · FY2025 · MH
Wisconsin Registry for Alzheimer's Prevention: Biomarkers for Preclinical AD
$834,297Sterling C Johnson · University Of Wisconsin-Madison · R01 · FY2015 · AG
Neural Correlates of Apathy Across the Alzheimer's Disease Continuum
$834,296Gad Asher Marshall · Massachusetts General Hospital · R01 · FY2023 · AG
Translational addiction neurobiology
$834,218Elliot A Stein · National Institute On Drug Abuse · ZIA · FY2019 · DA
The wandering nerve: gateway to boost Alzheimer's disease related cognitive performance
$834,216Heidi Irma Jacobs · Massachusetts General Hospital · R01 · FY2023 · AG
Role of Neurotrophins in the Development of the Mammalian Nervous System
$834,125Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Trial to Reduce Antimicrobial Use in Nursing home residents with Alzheimer's disease and other Dementias (TRAIN-AD)
$834,102Susan L Mitchell · Hebrew Rehabilitation Center For Aged · R37 · FY2017 · AG